BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9793975)

  • 1. Hyperglycosylated hCG, a potential alternative to hCG in Down syndrome screening.
    Cole LA; Omrani A; Cermik D; Singh RO; Mahoney MJ
    Prenat Diagn; 1998 Sep; 18(9):926-33. PubMed ID: 9793975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG.
    Cole LA; Shahabi S; Oz UA; Rinne KM; Omrani A; Bahado-Singh RO; Mahoney MJ
    Prenat Diagn; 1999 Apr; 19(4):351-9. PubMed ID: 10327141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine hyperglycosylated hCG plus ultrasound biometry for detection of down syndrome in the second trimester in a high-risk population.
    Bahado-Singh R; Oz U; Shahabi S; Omrani A; Mahoney M; Cole L
    Obstet Gynecol; 2000 Jun; 95(6 Pt 1):889-94. PubMed ID: 10831986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal urine hyperglycosylated hCG in pregnancies with Down syndrome.
    Cuckle HS; Shahabi S; Sehmi IK; Jones R; Cole LA
    Prenat Diagn; 1999 Oct; 19(10):918-20. PubMed ID: 10521815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
    Talbot JA; Spencer K; Abushoufa RA
    Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy.
    Palomaki GE; Neveux LM; Haddow JE; Wyatt P
    Prenat Diagn; 2007 Sep; 27(9):808-13. PubMed ID: 17590886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies.
    Cole LA; Acuna E; Isozaki T; Palomaki GE; Bahado-Singh RO; Mahoney MO
    Prenat Diagn; 1997 Dec; 17(12):1125-33. PubMed ID: 9467809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
    Cole LA; Shahabi S; Oz UA; Bahado-Singh RO; Mahoney MJ
    Clin Chem; 1999 Dec; 45(12):2109-19. PubMed ID: 10585342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
    Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
    Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary hyperglycosylated hCG in first trimester screening for chromosomal abnormalities.
    Weinans MJ; Butler SA; Mantingh A; Cole LA
    Prenat Diagn; 2000 Dec; 20(12):976-8. PubMed ID: 11113909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester intact hCG as an early marker of trisomy 21: a promise unrecognised?
    Spencer K; Cowans NJ; Uldbjerg N; Vereecken A; Tørring N
    Prenat Diagn; 2008 Dec; 28(12):1156-9. PubMed ID: 19006100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-trimester marker ratios in prenatal screening for Down syndrome.
    Wald NJ; Bestwick JP; Morris JK
    Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialic acid-deficient invasive trophoblast antigen (sd-ITA): a new urinary variant for gestational Down syndrome screening.
    Sutton JM; Cole LA
    Prenat Diagn; 2004 Mar; 24(3):194-7. PubMed ID: 15057952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary free beta hCG, beta core fragment and total oestriol as markers of Down syndrome in the second trimester of pregnancy.
    Hsu JJ; Spencer K; Aitken DA; Crossley J; Choi T; Ozaki M; Tazawa H
    Prenat Diagn; 1999 Feb; 19(2):146-58. PubMed ID: 10215073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single serum test for measuring early pregnancy outcome with high predictive value.
    Sutton-Riley JM; Khanlian SA; Byrn FW; Cole LA
    Clin Biochem; 2006 Jul; 39(7):682-7. PubMed ID: 16765931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycosylated hCG: a variant with separate biological functions to regular hCG.
    Cole LA; Khanlian SA
    Mol Cell Endocrinol; 2007 Jan; 260-262():228-36. PubMed ID: 17081684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
    Wald NJ; Morris JK; Ibison J; Wu T; George LM
    Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.